| Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal inflammation B Chassaing, G Srinivasan, MA Delgado, AN Young, AT Gewirtz, ... Public Library of Science 7 (9), e44328, 2012 | 494 | 2012 |
| Lipocalin 2 deficiency dysregulates iron homeostasis and exacerbates endotoxin-induced sepsis G Srinivasan, JD Aitken, B Zhang, FA Carvalho, B Chassaing, ... The Journal of Immunology 189 (4), 1911-1919, 2012 | 139 | 2012 |
| Apoptosis inducing effect of plumbagin on colonic cancer cells depends on expression of COX-2 BR Subramaniya, G Srinivasan, SS Mohammed Sadullah, N Davis, ... PloS one 6 (4), e18695, 2011 | 110 | 2011 |
| Differential role of lipocalin 2 during immune complex–mediated acute and chronic inflammation in mice R Shashidharamurthy, D Machiah, JD Aitken, K Putty, G Srinivasan, ... Arthritis & Rheumatism 65 (4), 1064-1073, 2013 | 66 | 2013 |
| Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition G Srinivasan, GS Sidhu, EA Williamson, AS Jaiswal, N Najmunnisa, ... Cancer chemotherapy and pharmacology 80, 861-867, 2017 | 59 | 2017 |
| EEPD1 rescues stressed replication forks and maintains genome stability by promoting end resection and homologous recombination repair Y Wu, SH Lee, EA Williamson, BL Reinert, JH Cho, F Xia, AS Jaiswal, ... PLoS genetics 11 (12), e1005675, 2015 | 59 | 2015 |
| Endonuclease EEPD1 is a gatekeeper for repair of stressed replication forks HS Kim, JA Nickoloff, Y Wu, EA Williamson, GS Sidhu, BL Reinert, ... Journal of Biological Chemistry 292 (7), 2795-2804, 2017 | 35 | 2017 |
| MiR223-3p promotes synthetic lethality in BRCA1-deficient cancers G Srinivasan, EA Williamson, K Kong, AS Jaiswal, G Huang, HS Kim, ... Proceedings of the National Academy of Sciences 116 (35), 17438-17443, 2019 | 30 | 2019 |
| The splicing component ISY1 regulates APE1 in base excision repair AS Jaiswal, EA Williamson, G Srinivasan, K Kong, CL Lomelino, ... DNA repair 86, 102769, 2020 | 12 | 2020 |
| The emergence of model systems to investigate the link between traumatic brain injury and Alzheimer’s disease G Srinivasan, DA Brafman Frontiers in aging neuroscience 13, 813544, 2022 | 7 | 2022 |
| EEPD1 promotes repair of oxidatively-stressed replication forks AS Jaiswal, HS Kim, OD Schärer, N Sharma, EA Williamson, G Srinivasan, ... NAR cancer 5 (1), zcac044, 2023 | 6 | 2023 |
| BRCA1 mediates protein homeostasis through the ubiquitination of PERK and IRE1 R Hromas, G Srinivasan, M Yang, A Jaiswal, TA Totterdale, L Phillips, ... Iscience 25 (12), 2022 | 3 | 2022 |
| A humanized monoclonal antibody against the endothelial chemokine CCL21 for the diagnosis and treatment of inflammatory bowel disease ML Capitano, A Jaiswal, HE Broxmeyer, Y Pride, S Glover, FG Amlashi, ... Plos one 16 (7), e0252805, 2021 | 3 | 2021 |
| Lipocalin 2 mediated hypoferremia protects against endotoxin-induced sepsis in mice (112.11) M Vijay-Kumar, J Aitken, G Srinivasan, R Sashidharamurthy, D Jones, ... The Journal of Immunology 188 (1_Supplement), 112.11-112.11, 2012 | 3 | 2012 |
| TATDN2 resolution of R-loops is required for survival of BRCA1-mutant cancer cells AS Jaiswal, A Dutta, G Srinivasan, Y Yuan, D Zhou, M Shaheen, ... Nucleic acids research 51 (22), 12224-12241, 2023 | 1 | 2023 |
| Splicing component ISY1 interacts with APE1 and regulates base excision repair A Jaiswal, E Williamson, B Patel, G Srinivasan, K Kong, C Lomelino, ... Cancer Research 79 (13_Supplement), 1758-1758, 2019 | 1 | 2019 |
| MiR-223-3p promotes genomic stability of hematopoietic progenitors after radiation S Chen, G Srinivasan, A Jaiswal, EA Williamson, L Li, D Arris, D Zhou, ... Experimental Hematology 129, 104123, 2024 | | 2024 |
| PINE-TREE enables highly efficient genetic modification of human cell lines C Frisch, WW Kostes, B Galyon, B Whitman, SJ Tekel, K Standage-Beier, ... Molecular Therapy-Nucleic Acids 33, 483-492, 2023 | | 2023 |
| A microcarrier-based protocol for scalable generation and purification of human induced pluripotent stem cell-derived neurons and astrocytes J Knittel, G Srinivasan, C Frisch, N Brookhouser, S Raman, A Essuman, ... STAR protocols 3 (3), 101632, 2022 | | 2022 |
| Use of miR-223-3p as a cancer therapeutic and method for treating cancer using the same RA Hromas, E Williamson, G Srinivasan US Patent 11,365,415, 2022 | | 2022 |
